Cargando…
Opinion on the impact of non‐monotonic dose responses on EFSA′s human health risk assessments
This Opinion assesses the biological relevance of the non‐monotonic dose responses (NMDR) identified in a previous EFSA External Report (Beausoleil et al., 2016) produced under GP/EFSA/SCER/2014/01 and the follow‐up probabilistic assessment (Chevillotte et al., 2017a,b), focusing on the in vivo data...
Autores principales: | More, Simon, Benford, Diane, Hougaard Bennekou, Susanne, Bampidis, Vasileios, Bragard, Claude, Halldorsson, Thorhallur, Hernandez‐Jerez, Antonio, Koutsoumanis, Kostas, Lambré, Claude, Machera, Kyriaki, Mullins, Ewen, Nielsen, Søren Saxmose, Schlatter, Josef, Schrenk, Dieter, Turck, Dominique, Tarazona, Jose, Younes, Maged |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528485/ https://www.ncbi.nlm.nih.gov/pubmed/34712366 http://dx.doi.org/10.2903/j.efsa.2021.6877 |
Ejemplares similares
-
Guidance on protocol development for EFSA generic scientific assessments
por: More, Simon, et al.
Publicado: (2023) -
Draft for internal testing Scientific Committee guidance on appraising and integrating evidence from epidemiological studies for use in EFSA's scientific assessments
por: More, Simon, et al.
Publicado: (2020) -
Evaluation of existing guidelines for their adequacy for the food and feed risk assessment of microorganisms obtained through synthetic biology
por: More, Simon, et al.
Publicado: (2022) -
Guidance on the use of the benchmark dose approach in risk assessment
por: More, Simon John, et al.
Publicado: (2022) -
Statement on the derivation of Health‐Based Guidance Values (HBGVs) for regulated products that are also nutrients
por: More, Simon, et al.
Publicado: (2021)